128 related articles for article (PubMed ID: 9352263)
1. Lactobacillus species as emerging pathogens in neutropenic patients.
Fruchart C; Salah A; Gray C; Martin E; Stamatoullas A; Bonmarchand G; Lemeland JF; Tilly H
Eur J Clin Microbiol Infect Dis; 1997 Sep; 16(9):681-4. PubMed ID: 9352263
[TBL] [Abstract][Full Text] [Related]
2. Penicillin or vancomycin plus ceftazidime in febrile neutropenic patients after stem cell transplantation.
Kargar Samani K; Vandercam B; Straetmans N; Michaux L; Ferrant A
Acta Clin Belg; 2000; 55(5):279-84. PubMed ID: 11109643
[TBL] [Abstract][Full Text] [Related]
3. Pneumonia caused by Micrococcus species in a neutropenic patient with acute leukemia.
Salar A; Carratalà J; Fernández-Sevilla A; Marín D; Grañena A
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):546-8. PubMed ID: 9272395
[No Abstract] [Full Text] [Related]
4. Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins.
Steyaert S; Peleman R; Vaneechoutte M; De Baere T; Claeys G; Verschraegen G
J Clin Microbiol; 1999 Nov; 37(11):3778-9. PubMed ID: 10523601
[TBL] [Abstract][Full Text] [Related]
5. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Fanci R; Paci C; Martinez RL; Fabbri A; Pecile P; Leoni F; Longo G
J Chemother; 2000 Jun; 12(3):232-9. PubMed ID: 10877519
[TBL] [Abstract][Full Text] [Related]
6. [Endocarditis caused by Lactobacillus].
Urkijo JC; Montejo M; Mendoza MF; Aguirrebengoa K; Hernández JL; Aguirre C
Enferm Infecc Microbiol Clin; 1992 Jan; 10(1):32-3. PubMed ID: 1498171
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of combined vancomycin and pefloxacine in gastrointestinal decontamination for preventing infections after chemotherapy-induced bone marrow aplasia. A randomized double-blind study].
Thomas X; Troncy J; Belhabri A; Thiebaut A; Bouheddou N; Michallet M; Fleurette J; Pivot C; Fiere D; Archimbaud E
Presse Med; 2000 Oct; 29(32):1745-51. PubMed ID: 11098268
[TBL] [Abstract][Full Text] [Related]
8. Management of fever in neutropenic patients with different risks of complications.
Klastersky J
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of bacterial infections in neutropenic and immunocompromised patients].
Helbig W; Tauchnitz R
Z Gesamte Inn Med; 1992 Sep; 47(9):417-21. PubMed ID: 1441670
[TBL] [Abstract][Full Text] [Related]
10. Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Casali A; Santini S; Della Giulia M; Di Lauro L; Vici P; Gionfra T; Sega FM
J Exp Clin Cancer Res; 1997 Sep; 16(3):321-4. PubMed ID: 9387908
[TBL] [Abstract][Full Text] [Related]
11. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
12. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
[TBL] [Abstract][Full Text] [Related]
13. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
14. Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin.
Dompeling EC; Donnelly JP; Deresinski SC; Feld R; Lane-Allman EF; De Pauw BE
Eur J Cancer; 1996 Jul; 32A(8):1332-9. PubMed ID: 8869095
[TBL] [Abstract][Full Text] [Related]
15. Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Marie JP; Vekhoff A; Pico JL; Guy H; Andremont A; Richet H
J Antimicrob Chemother; 1998 Jun; 41 Suppl D():57-64. PubMed ID: 9688452
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.
Cruciani M; Rampazzo R; Malena M; Lazzarini L; Todeschini G; Messori A; Concia E
Clin Infect Dis; 1996 Oct; 23(4):795-805. PubMed ID: 8909847
[TBL] [Abstract][Full Text] [Related]
17. Empirical therapy of infections in neutropenic patients.
Gaya H
Br J Haematol; 1998 May; 101 Suppl 1():5-9. PubMed ID: 9607734
[No Abstract] [Full Text] [Related]
18. [Neutropenia with fever].
Ben Ali A
Presse Med; 1999 Nov; 28 Suppl 3():9-10. PubMed ID: 10605460
[TBL] [Abstract][Full Text] [Related]
19. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia.
Rubin M; Hathorn JW; Marshall D; Gress J; Steinberg SM; Pizzo PA
Ann Intern Med; 1988 Jan; 108(1):30-5. PubMed ID: 3337513
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.
Broun ER; Wheat JL; Kneebone PH; Sundblad K; Hromas RA; Tricot G
Antimicrob Agents Chemother; 1994 Mar; 38(3):576-9. PubMed ID: 8203857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
